Chaihushugan Decoction and Wen Dan Tang for Insomnia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorTainan Hospital, Ministry of Health and Welfare
About this trial
This study aims to evaluate the clinical effectiveness of Traditional Chinese Medicine (TCM) in treating sleep disorders, specifically chronic insomnia. While conventional TCM treatments often rely heavily on subjective patient feedback, this clinical trial incorporates objective diagnostic tools, including Digital Polysomnography (PSG) and actigraphy, to gather data-driven sleep quality metrics.
Participants will be randomly assigned to receive either Chaihushugan Decoction or Wen Dan Tang for an 8-week treatment period. Subjective improvements will be tracked using standardized clinical questionnaires such as the Insomnia Severity Index (ISI) and Pittsburgh Sleep Quality Index (PSQI). The findings from this trial will help clarify the scientific basis and treatment pathways of these two classic herbal formulations for sleep management.
Eligibility criteria
Qualifiers
Patients aged 20 or older seeking treatment at the Traditional Chinese Medicine outpatient clinic with sleep disorders.
Meet the diagnostic criteria for chronic insomnia according to the International Classification of Sleep Disorders, Third Edition (ICSD-3).
Willing to receive traditional Chinese medicine treatment.
Able to provide signed informed consent approved by the National Cheng Kung University Hospital Institutional Review Board.
Disqualifiers
Diagnosed with schizophrenia or narcolepsy.
History of neurological diseases (e.g., stroke history, neurodegenerative diseases).
History of alcohol or drug addiction.
Experiencing major, uncontrollable life-altering stressors (e.g., recent bereavement).
Trial design
Treatments tested in this trial
- Chaihushugan Decoction
- Wen Dan Tang
Treatment groups
24 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov